Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 263-273, February 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watanabe, M.
Right arrow Articles by Morris, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watanabe, M.
Right arrow Articles by Morris, H. P.

Benzpyrene Hydroxylase Activity and Its Induction by Methylcholanthrene in Morris Hepatomas, in Host Livers, in Adult Livers, and in Rat Liver during Development1

Minro Watanabe2, Van R. Potter and Harold P. Morris3

McArdle Laboratory for Cancer Research, Medical Center, University of Wisconsin, Madison, Wisconsin 53706

Benzpyrene hydroxylase activity and its induction by a single injection of methylcholanthrene (2 mg/100 g body weight) were studied in liver from rats during developmental stages and in Morris Hepatomas 9618A, 9633, 7800, 7794A, and 8999 under controlled feeding conditions. The purpose of the experiment was to see whether naturally occurring levels of benzpyrene hydroxylase are lower in activity among the different hepatoma lines than in adult liver or newborn liver and whether induced levels of the activity in hepatoma by methylcholanthrene treatment could be referred to those induced in liver from rats of normal developmental stages.

Benzpyrene hydroxylase activity in Hepatoma 9633 is very low, but after administration of methylcholanthrene the activity was markedly increased, with some modification by variations in the time of injection. The benzpyrene hydroxylase activities in the host livers were strongly influenced by the size of the pooled hepatoma in rats bearing Hepatoma 8999 but not in rats bearing Hepatoma 9618A, while in the latter an influence of feeding regimen was shown.

Methylcholanthrene was able to induce benzpyrene hydroxylase activity in Morris hepatomas as well as in the corresponding host liver, although the induced levels in hepatomas were always lower than those in the host liver. There was no consistency of the induced levels among hepatoma lines, although all the rats were sacrificed exactly 6 hr after onset of feeding under controlled dietary regimens and 24 hr after a single intraperitoneal treatment with methylcholanthrene.

Benzpyrene hydroxylase in fetal rat liver was very low in activity, and after birth a marked increase was observed. After administration of methycholanthrene the fetal liver showed some increase in benzpyrene hydroxylase activities and in neonatal stages more profound responses were detected. The activity of benzpyrene hydroxylase and the magnitude of the induced levels in normal rat liver were completely dependent upon the age of the rat, and there were no differences in activity between male and female rats until after 21 days of age. The similarity of hepatoma lines to normal rat liver during developmental stages with respect to the activity of benzpyrene hydroxylase and its response to methylcholanthrene induction were discussed.

1 This study was supported in part by Departmental Grant CA-07175 and Training Grant T01-CA-5002 from the National Cancer Institute, USPHS. This paper is the sixth in the series entitled, "The Comparative Enzymology and Cell Origin of Rat Hepatomas."

2 Postdoctoral fellow, Damon Runyon Memorial Fund for Cancer Research, 1966 to 1968. Present address: The Research Institute for Tuberculosis, Leprosy and Cancer, Tohoku University, Sendai, Japan.

3 Present address: Department of Biochemistry, College of Medicine, Howard University, Washington, D. C. 20001. Supported in part by USPHS Grant No. CA-10729.

Received 1/10/69. Accepted 5/26/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.